Vol. 1, Issue 2, 2021November 01, 2021 EDT
Patients with Mood Disorders Require Higher Doses of Buprenorphine for Management of Opioid Use Disorder but Have No Increased Risk of Neonatal Abstinence Syndrome
Patients with Mood Disorders Require Higher Doses of Buprenorphine for Management of Opioid Use Disorder but Have No Increased Risk of Neonatal Abstinence Syndrome
Tonismae, Tiffany, Misty McDowell, Loraine Torres, James E. Slaven, Sara K. Quinney, Frank Schubert, and Mary Pell Abernathy. 2021. “Patients with Mood Disorders Require Higher Doses of Buprenorphine for Management of Opioid Use Disorder but Have No Increased Risk of Neonatal Abstinence Syndrome.” North American Proceedings in Gynecology & Obstetrics 1 (2): 24–31. https://doi.org/10.54053/001c.29762.
Powered by Scholastica, the modern academic journal management system